Clinical trial
Duloxetine Versus Paroxetine for Major Depression
NCT00489775 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00489775 |
|---|---|
| Title | Duloxetine Versus Paroxetine for Major Depression |
| Official title | Duloxetine Versus Paroxetine in the Acute Treatment of Major Depression |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Major Depressive Disorder |
| Intervention type | Drug |
| Interventions | Duloxetine, Paroxetine |
| Enrollment | 480 |
| Start date | Jan 1, 2004 |
| Completion | Jun 1, 2005 |
| First posted | Jun 21, 2007 |
| Last update posted | Jun 21, 2007 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: